Differential effects of nitric oxide synthase inhibitors on anxiety in unstressed and stressed mice

Indian Journal of Experimental Biology

Volumn 48, Issue 4, 2010, Pages 365-372

  Gilhotra, Neeraj ^a,b   Jain, Harshita ^b   Dhingra, Dinesh ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b SURESH GYAN VIHAR UNIVERSITY   (India)

Author keywords

Anxiety; Immobilization; Nitric oxide synthase

Indexed keywords

7 NITROINDAZOLE; 7-NITROINDAZOLE; AMINOGUANIDINE; ANXIOLYTIC AGENT; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; INDAZOLE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NITRITE; NOS1 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL; ANXIETY; ARTICLE; BLOOD; DARKNESS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXERCISE; LIGHT; MAZE TEST; MENTAL STRESS; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DARKNESS; ENZYME INHIBITORS; GUANIDINES; INDAZOLES; LIGHT; MAZE LEARNING; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PYRROLIDINES; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; THIOCARBAMATES;

MUS;

EID: 77954253940     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Ninan P T, Recent Perspectives on the Diagnosis and Treatment of Generalized Anxiety Disorder, Am J Managed Care, 7 (2001) S367.
2. DSM-IV, Diagnostic and statistical manual of mental disorders, Fourth ed. (American Psychiatric Association, Washington, DC) 1994.
3. Barbee J G, Mixed symptoms and syndromes of anxiety and depression: Diagnostic, prognostic, and etiologic issues, Ann Clin Psychiatry, 10 (1998) 15.
4. McEwen B S, Allostasis and allostatic load: Implications for neuropsychopharmacology, Neuropsychopharmacology, 22 (2000) 108.
5. McEwen B S & Magarinos A M, Stress effects on morphology and function of the hippocampus, Ann NY Acad Sci, 821 (1997) 271.
6. McEwen B S, Protective and damaging effects of stress mediators, N Engl J Med, 338 (1998) 171.
7. Sullivan G M, Coplan J D & Gorman J M, Psychoneuroendocrinology of anxiety disorders, Psychiatr Clin North Am, 21 (1998) 397.
8. Bhattacharya S K & Bhattachatyya D, Effect of restraint stress on rat brain serotonin, J Biosci, 4 (1982) 269.
9. Korte S M & De Boer S F, A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze, Eur J Pharmacol, 463 (2003) 163.
10. McBlane J W & Handley S L, Effects of two stressors on behavior in the elevated X maze: Preliminary investigation of their interaction with 5-OH-DPAT, Psychopharmacology (Berl), 116 (1994) 173.
11. Hata T, Nishikawa H, Itoh E & Funakami Y, Anxiety like behavior in elevated plus maze test in repeatedly cold stressed mice, Jpn J Pharmacol, 85 (2001) 189.
12. Britton K T, McLeod S, Koob G F & Hauger R, Pregnane steroid alphaxelone attenuates anxiogenic behavioral effects of corticotrophic releasing factor and stress, Pharmacol Biochem Behav, 41 (1992) 399.
13. Adamec R E, Sayin U & Brown A, The effects of corticotrophic releasing factor (CRF) and handling stress on behavior in elevated plus maze test of anxiety, J Psychopharmacol, 5 (1991) 175.
14. Heinrichs S C, Pich E M, Miczeck K A, Britton K T & Koob G F, Corticotrophic releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action, Brain Res, 581 (1992) 190.
15. Alobnetti M E & Farabollini P, Behavioral responses to a single and repeated restraint in male and female rats, Behav Proc, 28 (1992) 97.
16. Beijamini V & Guimaraes F S, Activation of neurons containing the enzyme nitric oxide synthase following exposure to an elevated plus maze, Brain Res Bull, 69 (2006) 347.
17. Belzung C & Griebel G, Measuring normal and pathological anxiety-like behaviour in mice: A review, Behav Brain Res, 125 (2001) 141.
18. Millan M J, The neurobiology and control of anxious states, Prog Neurobiol, 70 (2003) 83.
19. Bilbo SD, Hotchkissb AK, Chiavegattoa S & Nelson RJ, Blunted stress responses in delayed type hypersensitivity in mice lacking the neuronal isoform of nitric oxide synthase, J Neuroimmunol, 140 (2003) 41.
20. Gow A J, Farkouh C R, Munson D A, Posencheg M A & Ischiropoulos H, Biological significance of nitric oxide-mediated protein modifications, Am J Physiol Lung Cell Mol Physiol, 287 (2004) L262.
21. Esch T, Stefano G B, Fricchione G L & Benson H, The role of stress in neurodegenerative diseases and mental disorders, Neuro Endocrinol Lett, 23 (2002) 199.
22. Sevgi S, Ozek M & Eroglu L, L-NAME prevents anxietylike and depression-like behavior in rats exposed to restraint stress, Methods Find Exp Clin Pharmacol, 28 (2006) 95.
23. Kim C K & Rivier C L, Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats, Endocrinology, 141 (2000) 2244.
24. Harada S, Imaki T, Chikada N, Naruse M & Demura H, Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolysaccharide injection, Brain Res, 821 (1999) 322.
25. Heinrichs S C, Menzanghi F, Pich E M, Baldwin H A, Rassnick S, Britton K T & Koob G F, Anti-stress action of corticotrophin-releasing factor antagonist on behavioral reactivity to stressors of varying types and intensity, Neuropsychopharmacology, 11 (1994) 179.
26. Quock R M & Nguyen E, Possible involvement of nitric oxide in chlordiazepoxide-induced anxiolysis in mice, Life Sci, 51 (1992) L255.
27. Monzón M E, Varas M M & De Barioglio S R, Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain, Peptides, 22 (2001) 1043.
28. Roohbakhsh A, Moghaddam A H, Massoudi R & Zarrindast M R, Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test, Clin Exp Pharmacol Physiol, 34 (2007) 223.
29. Volke V, Soosar A, Koks S, Bourin M, Mannisto P T & Vasar E, 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety, Psychopharmacology, 131 (1997) 399.
30. Yildiz F, Ulak G, Erden B F & Gacar N, Anxiolytic-like effects of 7-Nitroindazole in the rat plus-maze test, Pharmacol Biochem Behav, 65 (2000) 199.
31. Forestiero D, Manfrim C M, Guimarães F S & de Oliveira R M, Anxiolytic -like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats, Psychopharmacology (Berl), 184 (2006) 166.
32. Spolidório P C, Echeverry M B, Iyomasa M, Guimarães F S & Del Bel E A, Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus, Psychopharmacology (Berl), 195 (2007) 183.
33. Stuehr D J & Marletta M A, Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-α, J Immunol, 139 (1987) 518.
34. Förstermann U & Kleinert H, Nitric oxide synthase: Expression and expressional control of the three isoforms, Naunyn-Schmiedeberg's Arch Pharmacol, 352 (1995) 351.
35. Olivenza R, Moro M A, Lizasoain L, Lorenzo P, Fernández A P, Rodrigo J, Boscá L & Leza J C, Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex, J Neurochem, 74 (2000) 785.
36. Madrigal J L, Moro M A, Lizasoain I, Lorenzo P, Castrillo A, Boscá L & Leza J C, Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappa B-mediated mechanisms, J Neurochem, 76 (2001) 532.
37. KB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress, Neuropsychopharmacology, 26 (2002) 155.
38. Sheline Y I, Wang P W, Gado M H & Csernansky J G, Hippocampal atrophy in recurrent major depression, Proc Natl Acad Sci USA, 93 (1996) 3908.
39. Sapolsky R, Uno H, Robert C & Finch C, Hippocampal damage associated with prolonged glucocorticoid exposure in primates, J Neurosci, 10 (1990) 2897.
40. Southan J G & Szabo C, Selective pharmacological inhibition of distinct nitric oxide synthase isoforms, Biochem Pharmacol, 51 (1996) 383.
41. Gilhotra N & Dhingra D. Involvement of NO-cGMP pathway in antianxiety effect of aminoguanidine in stressed mice, Prog Neuro-Psychopharmacol Biol Psychiatry, 33 (2009) 1502.
42. Xie Q-W, Kashiwabara Y & Nathan C, Role of transcription factor NF-KB/Rel in induction of nitric oxide synthase, J Biol Chem, 269 (1994) 4705.
43. Matek R, Borowiczl K K, Jargietto M & Czuczwar S J, Role of nuclear factor- kB in the central nervous system, Pharmacol Reports, 59 (2007) 25.
44. Schreck G, Meier B, Daniela N, Mannel, Wulf Dr6ge & Patrick A B, Dithiocarbamates as Potent Inhibitors of Nuclear Factor KB Activation in Intact Cells, J Exp Med, 175 (1992) 1181.
45. Cryan J F & Holmes A. The ascent of mouse: Advances in modelling human Depression and anxiety, Nature Rev, 5 (2004) 775.
46. Kulkarni S K, Handbook of experimental pharmacology, 3rd ed. (Vallabh Prakashan, Delhi) 1999.
47. Crawley J & Goodwin F K, Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines, Pharmacol Biochem Behav, 13 (1980) 167.
48. Green L C, Wagner D A, Glogowski J, Skipper P L, Wishnock J S & Tannenbaum S R, Analysis of Nitrate, nitrite, and [N-15N]-labelled nitrate in biological fuids, Annal Biochem, 126 (1982) 131.
49. Calatayud F, Belzung C & Aubert A, Ethological validation and the assessment of anxiety-like behaviours: Methodological comparison of classical analyses and structural approaches, Behav Processes 67 (2004) 195.
50. Pokk P & Väli M. The effects of nitric oxide synthase inhibitors on behavior of small-platform-stressed mice in the plus maze test, Prog Neuro-Psychopharmacol Biol Psychiatry, 26 (2002) 241.
51. Kumari B, Kumar A & Dhir A. Protective effect of non-selective and selective COX-2 inhibitors in acute immobilization stress-induced behavioral and biochemical alterations, Pharmacol Rep, 59 (2007) 699.
52. Goyal R & Kumar A. Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice, Pharmacol Rep, 59 (2007) 284.
53. Fiore M, Alleva E, Probert L, Kollias G, Angelucci F & Aloe L. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha, Physiol Behav, 63 (1998)571.
54. Kumar A & Singh A. Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep-deprivation-induced behavioral alterations and oxidative damage in mice, Phytomedicine, 15 (2008) 577.
55. Schmidt H H H W & Walter U, NO at work, Cell, 78 (1994) 919.
56. De Oliveira RM, Aparecida Del Bel E, Mameda- Rosa ML, Padovan CM, Deakin JF & Guimarães FS. Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restraint in rats, Neurosci Lett, 289 (2000) 123.
57. Griscavage JM, Hobbs AJ & Ignarro LJ, Negative modulation of NOS by NO and nitroso compounds, in: Advances in pharmacology, nitric oxide: Biochemistry, molecular biology and therapeutic implications, Vol 34, edited by L Ignarro and F Murad (Academic Press, London) 1995, 215.
58. Harvey BH, Oosthuizen F, Brand L, Wegener G & Stein DJ. Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus, Psychopharmacology, 175 (2004) 494.
59. Grilli M & Memo M, Nuclear Factor-tcB/Rel Proteins. A point of convergence of signalling pathways relevant in neuronal function and dysfunction, Biochem Pharmacol, 57 (1999)1.
60. Clemens J A, Cerebral ischemia: Gene activation, neuronal injury, and the protective role of antioxidants, Free Radic Biol Med, 28 (2000) 1526.
61. Perkins N D, The Rel/NF-kB family: Friend and foe, Trends Biochem Sci, 25 (2000) 434.